XSTRATA LIMITED

Financial Health Assessment: XSTRATA LIMITED

1. Financial Health Score: A (Excellent) XSTRATA LIMITED receives a grade of A. This rating reflects an exceptionally robust financial constitution, characterized by an enormous capital base and the unconditional backing of a global parent conglomerate. The company shows no symptoms of financial distress and maintains a perfect bill of regulatory health.

2. Key Vital Signs * Capital Reserves (The Blood Supply): £1.51 Billion The company’s share capital stands at a staggering £1,515,685,785.50. In financial wellness terms, this represents an exceptionally strong and healthy blood supply. It indicates that the company is heavily capitalized, meaning it has vast financial reserves to absorb any operational shocks, fund future activities, or service debts without breaking a sweat. * Regulatory Pulse (Filing Compliance): Strong & Steady The company’s accounts are filed up to date (last made up to 31 December 2025) with no overdue filings for accounts or confirmation statements. A steady regulatory pulse shows disciplined administrative health; the patient is attending all its regular check-ups and following statutory hygiene practices. * Corporate Genetics (Ownership & Control): Glencore Consortium The People with Significant Control (PSC) register reveals that Glencore entities (including Glencore Services (UK) Ltd, Glencore Plc, and Glencore Group Corporation) hold over 75% of shares, over 75% of voting rights, and the right to appoint/remove directors. This means XSTRATA LIMITED possesses the corporate genetics of a global mining and commodities titan, granting it a highly resilient immune system against standalone market volatility. * Structural Adaptation (Historical Evolution) Previously known as XSTRATA PLC (before May 2013), the company transitioned to a Private Limited Company. This structural adaptation reflects a healthy, intentional shift from a publicly traded entity to a dedicated subsidiary role following the historic Glencore-Xstrata merger.

3. Diagnosis Based on the financial data, XSTRATA LIMITED is in peak financial condition and operates as a robust financial organism within a larger corporate body. Its primary business activity (SIC Code 82990: Other business support service activities) confirms it functions as a vital support organ—likely a holding, financing, or administrative vehicle—for the Glencore group rather than an operating company exposed to the daily wear-and-tear of the open market.

With net assets and share capital well in excess of a billion pounds, the company exhibits zero symptoms of financial anemia. The complete absence of regulatory delinquency further confirms that the business is not suffering from the administrative fatigue that often plagues distressed entities. Simply put, this is a financially flush, systemically important subsidiary with an immaculate statutory record.

4. Recommendations While the patient is in excellent health, maintaining long-term wellness requires ongoing care: * Monitor Intercompany Vitals: As a support entity within the Glencore group, XSTRATA LIMITED's health is deeply intertwined with its parent. It is important to routinely assess intercompany balances and funding arrangements to ensure that capital flows remain healthy and that the company is not being strained by group-wide financial leveraging. * Maintain Regulatory Hygiene: Continue the exemplary track record of timely filings. Even for a heavily capitalized entity, unnecessary statutory penalties or compliance fevers can create easily preventable administrative complications. * Strategic Purpose Check: Given the massive share capital, stakeholders should periodically evaluate whether this capital structure remains the most efficient vehicle for the group's current financial strategy, ensuring the company doesn't carry more capital than necessary for its operational purpose.